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Abstract
Mixed neuroendocrine-non-neuroendocrine neoplasms (MINEN) are rare tumors that 
consist of at least 30% of both neuroendocrine and non-neuroendocrine components. The 
data concerning the pathogenesis of MINEN suggest a monoclonal origin. We describe a 
spontaneously immortalized cell line derived from gastric MINEN called GNEN-1.  
Primary tumor consisted of components of high-grade neuroendocrine carcinoma  
and adenocarcinoma. The GNEN-1 cell line was initiated from metastatic tumor cells of 
peritoneal fluid and expresses a purely neuroendocrine phenotype. The GNEN-1 cell line 
grows as monolayers and has retained the neuroendocrine phenotype with positivity 
for chromogranin A in immunohistochemistry. Electron microscopy showed cytoplasmic 
dense core granules and axon hillocks. The karyotype revealed alterations typical of both 
adenocarcinoma and neuroendocrine carcinoma such as trisomy 7 and 8. GNEN-1 cells 
were also positive for stanniocalcin-1, a marker of poor prognosis in gastric carcinomas. 
Expression of several markers related to neuroendocrine tumors was found. There have 
been only a few studies on the pathogenesis of MINEN and management of the disease 
due to the rarity of this tumor type. Here we describe for the first time an immortalized cell 
line derived from mixed gastric NEN. The GNEN-1 line offers a tool for future research on 
gastric NEN.
Introduction
Mixed neuroendocrine-non-neuroendocrine neoplasm 
(MINEN) is a rare tumor that was reclassified in the latest 
WHO Classification of Tumours of the Digestive system (1). 
MINEN was originally described in 1924 (2). According to 
the definition, MINEN is a composite neoplasm containing 
both neuroendocrine and non-neuroendocrine 
(e.g. adenocarcinoma or squamous cell carcinoma) 
components. It was called MANEC in the 2010 Blue Book 
edition of Gastrointestinal Tract (GI) tumors, as most 
of the non-neuroendocrine components in GI tract are 
adenocarcinomas. By definition, a MINEN tumor should 
consist of two histologically and immunohistochemically 
discrete components, each of which constitutes at least 
30% of the tumor volume. Gastric MINENs can appear 
anywhere in the stomach, but most are found in the 
cardiac or antral region (1). There are also case reports of 
this mixed tumor in the urinary tract and nasal cavity (3, 
4). Specific etiological factors for MINENs are unknown. 
Merkel cell polyomavirus (MCPyV) has been detected in 
rare cases of gastric NEC (1).
The incidence of MINENs is unknown. Gastric tumors 
represent 20% of the mixed tumors in the digestive 
system, including the pancreatobiliary system (5). While 
the median overall survival of mixed tumors of the 
appendix has been reported to be 6.5 years (6), no reliable 
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tumors are no longer considered MINENs (2). No specific 
epidemiological data exist (7). Previous studies on MINEN 
tumors are mostly case reports with immunohistochemical 
and genetic studies of the tumor tissue. The pathogenesis 
of the MINEN tumor has been discussed, but most findings 
support the hypothesis that the exocrine and endocrine 
portions of the tumor are derived from the bidirectional 
differentiation of a common stem cell (8, 9, 10, 11).
Stanniocalcin 1 (STC1) is a 56-kD homodimeric protein 
with autocrine and paracrine functions that protect cells 
from hypoxia and oxidative stress (12). Expression of STC1 
has been shown to be a negative prognostic factor for gastric 
cancer (13). The role of STC1 in NE tumors is unknown. 
Other recently reported markers for neuroendocrine 
tumors include regenerating family member 4 (REG4), 
atonal BHLH transcription factor 1 (ATOH1 or MATH1), 
and antizyme inhibitor 2 (AZIN2) (14, 15). REG4 has been 
reported to inhibit apoptosis, but the molecular details 
remain unknown (15).
The insulinoma-associated 1 (INSM1) gene encodes a 
protein with five zinc-finger domains and is an important 
regulator of beta-cell development in the pancreas. INSM1 
has also been shown to have specificity and sensitivity in 
neuroendocrine lung tumors (16, 17). The ISL LIM homebox 
1 (ISL1) gene encodes a protein that binds to the insulin 
gene enhancer region and may regulate the insulin gene 
expression. ISL1 is also associated with neuroendocrine 
carcinoma of the lung and neuroendocrine cancer of the 
GI tract (18, 19).
Tumor cell lines offer versatile tools for studying the 
molecular biology of neoplasms. Here we describe the 
establishment and characterization of a spontaneously 
transformed cell line from a gastric MINEN, composed 
of high-grade neuroendocrine carcinoma and 
adenocarcinoma components. To the best of our 




A middle-aged person underwent a preoperative control 
for surgical cholecystectomy. Ultrasound imaging revealed 
an incidental finding of multiple liver metastases. No 
primary tumor was visualized in a full-body CT scan. 
Gastroscopy revealed an approximately 1-cm diameter 
mass with necrotic center at the border between the corpus 
and antrum. Biopsies were taken from the liver metastases 
and from the gastric tumor. Six rounds of chemotherapy 
(etoposide and cisplatin) were administered with a 
good initial response. However, disease progression was 
observed after 3 months. A trial with temodal-xeloda was 
a failure. The patient developed ascites with malignant 
cells and died 6 months after the initial findings of liver 
metastasis.
Primary tumor and metastasis
The gastric tumor revealed the following two morphological 
components: an adenocarcinoma of the intestinal subtype 
(Fig. 1C and D) and a high-grade neuroendocrine carcinoma 
(NEC) (Fig. 1A and B). Only the NEC component was found 
in the biopsies from the liver metastases (Fig. 1E and F). 
The immunohistochemical profiles of two components 
in the primary tumor and the liver metastasis are shown 
in Table 1. CGH on DNA from the primary gastric tumor 
showed amplifications in the areas 5p14.3-p12, 6q22.1-
qter, 8q22.2-q24.1, and the whole 17q arm in CGH. The 
main deletions were 16q and 17p whole arms and almost 
the entire chromosome 19.
Establishment of a cell line
Fresh ascites fluid containing malignant cells collected 
from disease progression was mixed with an equal 
volume of RPMI-1640 culture medium (Sigma–Aldrich) 
supplemented with 10% (V/V) fetal bovine serum (FBS) 
(Gibco and Thermo-Fisher) and 1% (V/V) antibiotics 
(penicillin 10,000 IU/mL and streptomycin 10 mg/mL) 
(Sigma–Aldrich) and placed on ∅ 10 cm cell culture dishes 
(Eppendorf AG 22331, Hamburg, Germany). Ascites 
was also centrifuged to pellet cells and the supernatant 
recovered and filtered through a 22-µm filter to obtain cell-
free fluid that was added as a supplement to early passages of 
the cultures. The cells were cultured at 37°C in a humidified 
atmosphere with 5% CO2 in air. After 2 weeks of culturing, 
colonies of adherent polygonic cells accumulated growing 
in RPMI-1640 medium with 10% FBS without addition of 
ascites fluid. Cell cultures reaching approximately 80% 
confluence were detached by treatment with trypsin-
versene (Lonza) for subculturing. The studies were started 
at passage 12 and ended at passage 36. The established cell 
line was named GNEN-1.
Growth dynamics of the cell line
The cells were passaged and grown in 5 × 3 wells of a 96-well 
plate. The cells were counted in three wells a day for 5 days. 
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An average was calculated from the triplets each day. The 
results are presented in the graph in Fig. 2.
GNEN-1 cells growth in semi-solid 
matrix, Matrigel®
GNEN-1 cells were first grown into spheroids; the spheroids 
were picked with a pipette and the cultured in semi-
solid matrix, Matrigel® according to the manufacturer’s 
instructions (Discovery Labware Inc., Bedford, MA, USA).
Histological and IHC stainings of the cell line
The paraffin blocks of the GNEN-1 cells (p.16) were cut and 
stained with Mayer’s hematoxylin and eosin (H&E) and 
AbPAS.
The GNEN-1 cells were cultivated on Lab-Tek®II 
Chamber slides with one well according to the 
manufacturer’s instructions. The passages used in the 
staining are given after the primary antibody in brackets.
The IHC staining of the GNEN-1 cell line was 
performed in two different ways, using manual technique 
and a fully automated staining instrument. The slides 
were fixed with 3.5% paraformaldehyde (PFA) in PBS. 
Permeabilization was performed with NP40. The primary 
antibodies, presented in Table 2, s (AZIN2 (p.16), REG IV 
(p.16), STC 1 (p.19), chromogranin A (p.16), MATH 1 (p.16), 
CD56 (p.18), and synaptophysin (p.18)) were diluted in 
DAKO REAL® antibody diluent (S2022, Dako/Agilent) 
and incubated overnight in +4°C. Secondary antibody 
(Vectastain Elite® ABC kit, Sec-IgG: anti-rabbit goat-Ig and 
anti-mouse Horse-Ig) was diluted in normal serum and 
PBS and incubated for 30 min in room temperature. The 
Avidin-biotin complex was made and used according to 
the manufacturer’s instructions (Vector Laboratories, 
Vectastain Elite® ABC kit, REF: PK-6102). Staining was 
Figure 1
H&E staining of the primary tumor and the 
metastasis. The neuroendocrine carcinoma (NEC) 
component of the primary tumor (A) ×10, (B) ×20. 
Some necrosis is seen between the tumor cells 
(asterisk). The adenocarcinoma (A, C) component 
of the primary tumor (C) ×10, (D) ×20. The ductal 
structures are visible. (E) The NEC component of 
the liver metastasis (E) ×10, (F) ×20. All the scale 
bars represent 200 µm.
Table 1 Immunohistochemistry of the primary tumors, both components and the metastasis.
Part CK-PAN CK-7 Chr-A SYP CD56 MIB-1 (%)
Prim. adeno-C. Neg. Pos. Pos./Neg. Neg. Pos./Neg. >80
Prim. neuroendo-C. Neg. Neg. Pos. Pos. Pos. >80
Met. neurtoendo- C. Pos. Neg. Pos. Pos. Pos. >80
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revealed with an aminoethyle-carbazole (AEC) and H2O2 
solution in 0.05 M sodium-acetate solution (pH 5).
A Ventana Benchmark Ultra instrument (Roche) 
was utilized for the INSM1 (p.21) and ISL1 (p.21) 
antibodies (Table 2). For these antibodies, pretreatment 
was performed using cell conditioning 1 buffer, pH8.5, 
20 min at 98°C. The incubation time for INSM1 was 48 
min at 36°C and for ISL1, 32 min at 36°C. The multimer-
based detection kits were used to detect and visualize 
the antibodies. UltraView Universal DAB Detection Kit 
(760–500, Roche) for ISL1 and OptiView DAB IHC 
Detection Kit (760–700, Roche) for INSM1. Separate 
amplification step was added to the protocol for ISL1 by 
using the amplification kit (760–099, Roche).
Finally, the slides were counterstained with Mayer’s 
hematoxylin (S3309, Dako) and mounted.
Negative controls were made for the manual stainings 
on GNEN-1 cells, according to the same procedure 
as mentioned above, except the primary antibody 
was excluded. Positive controls were made for the 
automized stainings (ISL1 and INSM1) according to the 
procedure above. Normal pancreas tissue was used for the 
positive controls.
Imaging
All images taken of the HE, Ab-PAS, and IHC slides were 
taken with Nikon Digital sight DS-Fi2 trough a Nikon 
Eclipse 80i microscope.
TEM
GNEN-1 cells were fixed with pre-warmed 2.5% (V/V) 
glutaraldehyde in culture medium at 37°C for 15 min, 
scraped off the plates, and pelleted by centrifugation. The 
pellets were further fixed in 2.5% glutaraldehyde for 1 h. 
The fixed sample was post-fixed by 1% osmium tetroxide, 
dehydrated in graded ethanol, and embedded in Epoxy 
LX-112 resin. Sections of 60–80 nm thickness were cut and 
were observed under a JEOL JEM1400 (Tokyo, Japan) at 80 
kV. Digital electron micrographs were taken by a Morada 
TEM digital camera (EMSIS GmbH, Muenster, Germany).
Table 2 Antibodies used in the immunohistochemical stainings done on the GNEN-1 cells.
Antibody Clone Dilution Manufacturer Product code Positive signal Controls
AZIN2 K3 1:400 Raised by us (34) Not available Nuclear and granular 
sytoplasmic
Rabbit-negative
REG IV Mouse 
monoclonal
1:50 Raised by us (35) Not available Membranous and 
cytoplasmic
Mouse-negative
STC 1 OTI6D12 1:200 OriGene  
Technologies, Inc.
TA810025 Granular cytoplasmic Mouse-negative
Chromogranin A PHE5 1:100 EMD Millipore 
corporation
MAB319 Granular cytoplasmic Mouse-negative
MATH 1 Rabbit 
polyclonal





1:200 Merck Millipore AB5032 Cytoplasmic Rabbit-negative
Synaptophysin 27G12 1:100 Leica Biosystems NCL-SYNAP-299 Cytoplasmic Mouse-negative
INSM1 A-8 1:75 Nordic Biosite AZC-F34730 Nuclear Pancreas-positive
ISL1 EP283 1:50 Bio SB BSB2975 Nuclear Pancreas-positive
Figure 2
(A and B) Native GNEN-1 cells on the growth surface. The cells grow in 
clusters adherent to each other and the growth surface. The cells have 
dendritic-like sprouts from the soma. Clear nucleoli are seen. (C) GNEN-1 
cells stained immunohistochemically with chromogranin A. Clear granular 
cytoplasmic staining can be seen as well as one mitotic figure (asterisk). 
All the scale bars represent 100 µm.
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Karyotype and multicolor FISH
Cell culturing and metaphase-fluorescence in situ 
hybridization (FISH) preparations were performed 
according to standard cytogenetic procedures (20). 
Multicolor FISH karyotyping was performed with a 24XCYte 
mFISH probe kit (MetaSystems GmbH, Altslussheim, 
Germany). Hybridizations and post-hybridization 
washes were performed according to the manufacturers’ 
instructions. A Zeiss Axioplan 2 Microscope equipped 
with specific filters was used. Captured images were 
processed using the Isis/Multicolor FISH imaging system 
(MetaSystems). Cells used in mFISH were from passage 16.
Comparative genomic hybridization
The DNA used for the CGH was isolated using a proteinase 
K-based method according to Behringer et al. (21). Proteinase 
K was obtained from Thermo Fisher Scientific Baltics UAB 
(V.A. Graiciuno 8, LT-02241, Vilnius, Lithuania). CGH was 
performed with tumor cell DNA isolated from passage 
16 using the Cancer+SNP 4 3 180k micro-array (Oxford 
Gene Technology, Oxford, UK). Labeling, hybridization, 
scanning, and analysis were performed according to 
the manufacturers’ instructions. Microarray slides were 
scanned using an Agilent DNA Microarray Scanner G2505 
(Agilent Technologies Inc ) and filtered with Feature 
Extraction software v12.0.07 (Agilent Technologies). 
Cytosure Software v4.9 (hg19) (Oxford Gene Technology) 
was used for graphic analysis of the data.
qPCR method
RNA was isolated from GNEN-1 cells with TRI REAGENT® 
by Sigma–Aldrich according to the manufacturer’s 
instructions from passage 12. cDNA was generated from 
RNA with the Applied Biosystems High Capacity RNA to 
cDNA Kit® and it was used as a template for RT-PCR with 
gene-specific primers for STC1 and positive control GAPDH.
The primers used for STC1 were forward 
5’-ACAGCAAGCTGAATGTGTGC-3’ and reverse 
5’-CAGGCTTCGGACAAGTCTGT-3’. The GAPDH primers 
used were forward 5’-GGTGAAGGTCGGAGTCAAC-3’ and 
reverse 5’-CAAATGAGCCCCAGCCTTC-3’.
RT-PCR
RT-PCR was performed to investigate the presence of 
Merkel cell polyomavirus in the GNEN-1 cells. The 
DNA for the PCR was isolated from a passage 12 of 
the cell line as mentioned above. Protein tyrosine 
phosphatase receptor gamma (PTPRG, located on 
3p14.2) and LT3 of MCPyV were used as reference 
and target genes, respectively. The primers used were 
PTPRG forward 5’-TATGGGAGTGTGGGATGGT-3’ and 
reverse 5’-TAAGCTGGGAGGATCGCTTA-3’ and LT3 
forward 5’-TTGTCTCGCCAGCATTGTAG-3’ and reverse 
5’-ATATAGGGCCTCGTCAACC-3’. The PCR cycling 
conditions consisted of an initial denaturation step at 
95°C for 4 min, followed by 50 cycles with denaturation 
at 95°C for 30 s, annealing at 60°C for 30 s, and elongation 
at 72°C for 45 s. The final elongation step was performed 
at 72°C for 7 min. PCR was performed using a BioRad® CFX 
qPCR instrument. The virus positive control sample was 
from a Merkel cell carcinoma cell line MKL-1 (Cat. Nr. 
09111801, ECACC). The negative control was water.
Results
Cell line morphology and growth
GNEN-1 cells grew as small cell islands in a monolayer 
(colonies). Upon extended culturing, the cells merged 
to confluence (Fig. 3). Single GNEN-1 cells frequently 
made dendrite-like sprouts. Immunocytochemically, 
the cells retained the NE differentiation; cytokeratin 
and chromogranin were positive (Fig. 3). Transmission 
electron microscopy revealed dense-core granules, GAP 
junctions, neurofilaments, and axon hillocks (Fig. 4). The 
kinetics of proliferation is shown in Fig. 2. GNEN-1 cells 
grew in a linear fashion, before reaching confluence. The 
duplication time for GNEN-1 cells was approximately 
0.7 days and reached confluence in 3.5 days. The decrease 
in cells after day 4 represents cell death because of lack of 
growth surface. GNEN-1 cells grew as spheroids but did not 
invade semi-solid medium (Matrigel®) (data not shown).
Karyotype of the GNEN-1 cell line
M-FISH revealed several trisomies in the karyotype of the 
GNEN-1 cell line. The modal chromosomal number was 
approximately 52. Recurrent translocations were t(3;8), 
t(5;19), t(6;11), and t(3;11). The karyotype also revealed tris 
omies of chromosomes 1, 7, 8, 10, and 17 and deletion of 
chromosome 22.
Comparative genomic hybridization (CGH) of the 
GNEN-1 cell line
CGH performed with extracted DNA from the cell line 
revealed a chaotic structure of the chromosomes. The 
This work is licensed under a Creative Commons 
Attribution-NonCommercial 4.0 International License.https://doi.org/10.1530/EC-21-0206
https://ec.bioscientifica.com © 2021 The authors
Published by Bioscientifica Ltd
Downloaded from Bioscientifica.com at 11/26/2021 03:14:53PM
via free access





main findings were amplification of 8q24.21 where the 
MYC gene is located and amplification of 19q12, where 
the gene for Cyclin E1 (CCNE1) is located. There was 
also amplification on 3q28 containing the gene for 
tumor protein 63 (TP63) and loss in the loci of the tumor 
suppressor gene retinoblastoma 1 (RB1) (13q14.2). Loss 
of the loci containing the genes phosphatase and tensin 
homolog (PTEN) (10q23.31) was also observed.
Immunohistochemistry of the cell line
The GNEN-1 cell line stained positive for Synaptophysin 
and CD56, both are cytoplasmic granular staining, as 
shown in Fig. 5B and D. Nuclear staining was seen for ISL1 
and INSM1 (Fig. 6).
Stanniocalcin-1 in the GNEN-1 cell line
Results from the qPCR performed on GNEN-1 cells revealed 
the presence of the following transcripts: GAPDH and STC1 
in the same magnitude. GNEN-1 cells also stained positive 
for STC1 protein in immunohistochemistry (Fig. 7).
NE-related markers in GNEN-1 cell line
The GNEN-1 cells stained positively for AZIN2, REG4, and 
MATH1 (Fig. 7). AZIN2 staining was observed as small 
granules in the cytoplasm or in the nucleus. REG4 was 
positive mostly on the cell membrane and no nuclear 
positivity was observed. Expression of MATH1 was 
observed in the cytosol of GNEN-1 cells. The GNEN-1 cell 
line did not contain MCPyV-DNA when investigated by 
RT-PCR.
Discussion
Here we report a spontaneously immortalized continuous 
cell line called GNEN-1. GNEN-1 was established from 
a gastric mixed neuroendocrine-non-neuroendocrine 
(MINEN) tumor composed of adenocarcinoma and high-
grade neuroendocrine carcinoma. We believe that this cell 
line will offer a tool for further research on MINEN tumors.
The in vitro morphology of the GNEN-1 cell line 
showed features of a neuroendocrine phenotype. Cells 
Figure 3
Transient electron microscopy (TEM) images of GNEN-1 cells. (A) Cell 
membranes of two cells showing GAP junctions (red arrow); scale bar 
represents 100 nm. (B) Dense core granules (asterisk), which are typical 
for neuroendocrine cells. Nucleoli (double asterix) is clearly visible in this 
picture. (C) Neurofilaments (black arrow) and dense core granules are 
visible. (D) An axon hillock is seen in the image, supporting the 
neuroendocrine differentiation. In panels B, C, D the scale bar represents 
200 nm.
Figure 4
Growth curve of GNEN-1 cells growing in vitro. The 
GNEN-1 cells grow in a linear fashion before 
reaching confluence, in approximately 3–5 days.
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stained positive for chromogranin A and electron 
microscopy revealed dense core granules, neurofilaments, 
and axon hillocks. The liver metastases contained only 
the NEC component, indicating that the neuroendocrine 
component was more aggressive. This also explains the 
phenotype of the cell line, as it was established from 
metastatic peritoneal fluid cells. According to some 
studies, this pattern of metastasis is typical for these mixed 
neoplasms (22, 23, 24).
The WHO criteria of MINEN state that both 
components should present at least 30% of the tumor 
volume. As the diagnosis of the primary tumor was 
performed on a biopsy, this kind of quantitative 
interpretation cannot be made in our case. However, at 
least two separate components, adenocarcinoma and high-
grade neuroendocrine carcinoma, were identified thus 
supporting the diagnosis of MINEN. From the biopsy tissue 
at least 30% of it represented one of the components which 
supports a MINEN diagnosis but does not fully prove the 
MINEN diagnosis according to WHO. The GNEN-1 cell line 
did not represent the adenocarcinoma part of the primary 
tumor, suggesting that cells recovered from the ascites did 
not contain adenocarcinoma differentiation. Another 
Figure 5
Immunohistochemistry of the NEC component of the primary tumor and 
GNEN-1 cells. (A) The NEC component of the primary tumor was stained 
with CD56. (B) GNEN-1 cells stained with CD56 diffusely in the cytoplasm. 
(C) The NEC component of the primary tumor stained with synaptophysin. 
(D) GNEN-1 cells stained with synaptophysin. The cells do not stain as 
evenly as with CD56, but clear cytoplasmic staining is seen. The scale bars 
represent 150 µm.
Figure 6
Automated immunohistochemistry with antibodies against (A) ISL1 with 
strong nuclear staining. Some of the nuclei are not stained (arrow). (B) 
INSM1 with some positivity in the nuclei (arrow). One of the cells is in 
anaphase (arrowhead). The scale bars represent 100 µm.
Figure 7
Immunohistochemistry of GNEN-1 cells against (A) AZIN2 where nuclear 
staining and some cytoplasmic granules are seen. (B) REG4 shows 
membranous staining with the lack of nuclear staining is seen. (C) MATH1 
with cytoplasmic staining with lack of nuclear staining is seen. (D) STC1 
with granular cytoplasmic and lack of nuclear staining. In panels A, B, C, 
the scale bar represents 100 µm and in D 50 µm.
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explanation could be that two cell types are combined in 
vitro, the most viable cell clone will eventually take over.
The results from FISH showed trisomy of 
chromosomes 7 and 8 in GNEN-1 cells. Trisomies in 
these chromosomes have been reported to play a role 
in gastric adenocarcinoma tumorigenesis (25). This 
feature also suggests adenocarcinoma differentiation of 
the GNEN-1 cell line. A single trisomy of chromosome 7 
has also been shown to occur in NEC derived from the 
breast (26).
Amplification of 19q12, which is found in many 
gastric adenocarcinomas (27), was also present in GNEN-
1. A gene in this locus codes for the CCNE1 protein (27), 
which contributes to the G1/S transition in the cell cycle. 
Overexpression of CCNE1 is found in many tumors (28). 
Gain in the TP63 gene was also observed in GNEN-1 
cells. TP63 is connected to adult stem/progenitor cell 
regulation (29).
The genetic alterations (CGH and M-FISH) were similar 
in the primary tumor compared to the GNEN-1 cell line. 
This supports the hypothesis that the GNEN-1 cell line is 
derived from the primary tumor of the patient.
Even though there are cases of gastric NECs with 
identified MCPyV DNA, this was not found in GNEN-1 (1).
The pathogenesis of the MINEN tumor is poorly 
understood. It is believed that these tumors are derived 
from pluripotent stem cells and the neuroendocrine 
component is derived from the adenocarcinoma (2, 30, 
31). It is possible that inactivation of the SMARCA4 gene 
on chromosome 19 pushes the adenocarcinoma cells to 
differentiate toward NEC cells (31, 32). It has also been 
shown that MINEN has more chromosomal abnormalities 
in the NEC component than in the adenocarcinoma 
component (2), which further supports this hypothesis. 
Scardoni et  al. (11) used microdissection to obtain 
exocrine and neuroendocrine cells from the same 
primary MINEN tumors. A comparison of the mutational 
profiles of the two components provided evidence for a 
monoclonal origin of the two cell types in five out of six 
tumors analyzed (11). Based on these observations, the 
possibilities are high that the GNEN-1 cell line is a true 
MINEN cell line, even though it has more features of NEC 
rather than adenocarcinoma.
Both the cell line and the NEC component of the 
primary tumor are stained positive with neuroendocrine 
correlated antibodies, both CD56 and synaptophysin 
(Fig. 5A, B, C and D). The cell line was also stained positive 
with the second-generation neuroendocrine markers (ISL1 
and INSM1) as seen in Fig. 6, which further indicates the 
neuroendocrine phenotype of the cell line.
Expression of STC1 RNA in the GNEN-1 cells may 
explain in part the poor outcome of the patient. High STC1 
expression indicates poor prognosis in gastric cancer. STC1 
expression is also connected with chemoresistance and 
invasive growth in hypoxia (13).
AZIN2 is associated with intracellular vesicle 
transport and secretion (33), which then associate with 
the neuroendocrine nature of the cell line and the 
dense core granules seen in TEM. ATOH1 and REG4 are 
expressed in neuroendocrine tumors, which supports the 
neuroendocrine phenotype of the GNEN-1 cell line (15). 
All tree previously mentioned markers were positive in the 
IHC of the cell line as shown in Fig. 7.
The strength of this research is that it presents a new 
tool for research on gastric neuroendocrine neoplasias. To 
the best of our knowledge, this is the first report of a cell 
line derived from a gastric MINEN. Previous publications 
consist mostly of case reports and some larger studies of 
clinical factors. All biomedical research performed thus far 
has been on tumor tissue.
The limitation of this report is that the primary 
tumor could not be investigated fully, because of the lack 
of tumor tissue from the biopsies, and because of that 
the primary tumor or the metastasis was never surgically 
removed, as is often the case with mixed neuroendocrine-
non-neuroendocrine tumors. MINEN tumors are often 
discovered at a disseminated stage of the disease and 
surgery is therefore not the treatment of choice.
In conclusion, we present a spontaneously 
immortalized cell line derived from an aggressive gastric 
MINEN tumor. In the future, the GNEN-1 cell line can be 
used as a tool to study pathogenesis of mixed gastric tumors 
in further detail. This cell line may also serve as a tool in the 
search for potential therapeutic targets.
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